Cargando…
Mimicking in-vivo exposures to drug combinations in-vitro: anti-tuberculosis drugs in lung lesions and the hollow fiber model of infection
Here, we evaluate protocol requirements to mimic therapeutically relevant drug concentrations at the site of infection (i.e. lung lesion) in an in-vitro hollow fibre model of infection using pulmonary tuberculosis as a paradigm. Steady-state pharmacokinetic profiles in plasma, lung tissue and lung l...
Autores principales: | Kloprogge, Frank, Hammond, Robert, Kipper, Karin, Gillespie, Stephen H., Della Pasqua, Oscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744479/ https://www.ncbi.nlm.nih.gov/pubmed/31519935 http://dx.doi.org/10.1038/s41598-019-49556-5 |
Ejemplares similares
-
Can phenotypic data complement our understanding of antimycobacterial effects for drug combinations?
por: Kloprogge, Frank, et al.
Publicado: (2019) -
Improving the Drug Development Pipeline for Mycobacteria: Modelling Antibiotic Exposure in the Hollow Fibre Infection Model
por: Maitra, Arundhati, et al.
Publicado: (2021) -
Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2016) -
Emergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis
por: Kloprogge, Frank, et al.
Publicado: (2022) -
Modelling and simulation as research tools in paediatric drug development
por: Bellanti, Francesco, et al.
Publicado: (2011)